Michael Makhinson

Title(s)HS Clinical Professor, Psychiatry and Biobehavioral Sciences
SchoolMedicine
ORCID ORCID Icon0000-0001-6493-9699 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    UCLA, Los Angeles, CAB.S.06/1994Biochemistry
    UCLA, Los Angeles, CAM.D.06/2001Medicine
    UCLA, Los Angeles, CAPh.D.06/2001Neuroscience
    UCLA, Los Angeles, CA06/2005Psychiatry Residency

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Regulatory and Service System Challenges in Accessing Electroconvulsive Therapy for Catatonia in the Presence of Autism Spectrum Disorder. J Am Acad Child Adolesc Psychiatry. 2024 Mar; 63(3):293-295. Couse M, Makhinson M, Kelly P. PMID: 37778726.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. Ethics consultation in patients with behavioral and psychological symptoms of dementia. Clinical Ethics. 2023. Makhinson M, Gomez-Makhinson J, Jennings C, and Huerta, S . View Publication.
    3. The iatrogenic opioid crisis: An example of 'institutional corruption of pharmaceuticals'? J Eval Clin Pract. 2021 10; 27(5):1033-1043. Makhinson M, Seshia SS, Young GB, Smith PA, Stobart K, Guha IN. PMID: 33760335.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    4. Psychotic mania associated with topical ketamine in a patient with thoracic spine injury. Bipolar Disord. 2019 08; 21(5):463-464. Valdez DMC, Makhinson M. PMID: 31069894.
      View in: PubMed   Mentions:    Fields:    
    5. Gating the holes in the Swiss cheese (part I): Expanding professor Reason's model for patient safety. J Eval Clin Pract. 2018 02; 24(1):187-197. Seshia SS, Bryan Young G, Makhinson M, Smith PA, Stobart K, Croskerry P. PMID: 29168290; PMCID: PMC5901035.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    6. 'Cognitive biases plus': covert subverters of healthcare evidence. Evid Based Med. 2016 Apr; 21(2):41-5. Seshia SS, Makhinson M, Young GB. PMID: 26612071.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    7. Evidence-informed person-centred health care (part II): are 'cognitive biases plus' underlying the EBM paradigm responsible for undermining the quality of evidence? J Eval Clin Pract. 2014 Dec; 20(6):748-58. Seshia SS, Makhinson M, Young GB. PMID: 25494630.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    8. Evidence-informed person-centered healthcare part I: do 'cognitive biases plus' at organizational levels influence quality of evidence? J Eval Clin Pract. 2014 Dec; 20(6):734-47. Seshia SS, Makhinson M, Phillips DF, Young GB. PMID: 25429739.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    9. A successful treatment of buprenorphine withdrawal with the dopamine receptor agonist pramipexole. Am J Addict. 2014 Sep-Oct; 23(5):475-7. Makhinson M, Gomez-Makhinson J. PMID: 24628996.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    10. Successful treatment of co-occurring catatonia and obsessive-compulsive disorder with concurrent electroconvulsive therapy and benzodiazepine administration. J ECT. 2012 Sep; 28(3):e35-6. Makhinson M, Furst BA, Shuff MK, Kwon GE. PMID: 22914637.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    11. Biases in the evaluation of psychiatric clinical evidence. J Nerv Ment Dis. 2012 Jan; 200(1):76-82. Makhinson M. PMID: 22210366.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Biases in medication prescribing: the case of second-generation antipsychotics. J Psychiatr Pract. 2010 Jan; 16(1):15-21. Makhinson M. PMID: 20098227.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. Electroconvulsive therapy for depression in a patient with an intracranial arachnoid cyst. J ECT. 2009 Mar; 25(1):64-6. Desseilles M, Thiry JC, Monville JF, Ansseau M, Makhinson M. PMID: 19258863.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    14. A novel role for cyclic guanosine 3',5'monophosphate signaling in synaptic plasticity: a selective suppressor of protein kinase A-dependent forms of long-term potentiation. Neuroscience. 2006 Jun 30; 140(2):415-31. Makhinson M, Opazo P, Carlisle HJ, Godsil B, Grant SG, O'Dell TJ. PMID: 16549271; PMCID: PMC1832102.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    15. Adenylyl cyclase activation modulates activity-dependent changes in synaptic strength and Ca2+/calmodulin-dependent kinase II autophosphorylation. J Neurosci. 1999 Apr 01; 19(7):2500-10. Makhinson M, Chotiner JK, Watson JB, O'Dell TJ. PMID: 10087064; PMCID: PMC6786061.
      View in: PubMed   Mentions: 39     Fields:    Translation:AnimalsCells
    16. Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature. 1998 Dec 03; 396(6710):433-9. Migaud M, Charlesworth P, Dempster M, Webster LC, Watabe AM, Makhinson M, He Y, Ramsay MF, Morris RG, Morrison JH, O'Dell TJ, Grant SG. PMID: 9853749.
      View in: PubMed   Mentions: 455     Fields:    Translation:AnimalsCells
    17. Postsynaptic complex spike bursting enables the induction of LTP by theta frequency synaptic stimulation. J Neurosci. 1998 Sep 15; 18(18):7118-26. Thomas MJ, Watabe AM, Moody TD, Makhinson M, O'Dell TJ. PMID: 9736635; PMCID: PMC6793261.
      View in: PubMed   Mentions: 86     Fields:    Translation:AnimalsCells
    18. 5-Hz stimulation of CA3 pyramidal cell axons induces a beta-adrenergic modulated potentiation at synapses on CA1, but not CA3, pyramidal cells. Brain Res. 1998 May 25; 794(1):75-9. Moody TD, Thomas MJ, Makhinson M, O'Dell TJ. PMID: 9630529.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    19. Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat Genet. 1997 May; 16(1):28-36. Smith DJ, Stevens ME, Sudanagunta SP, Bronson RT, Makhinson M, Watabe AM, O'Dell TJ, Fung J, Weier HU, Cheng JF, Rubin EM. PMID: 9140392.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansAnimalsCells
    20. Activity-dependent beta-adrenergic modulation of low frequency stimulation induced LTP in the hippocampal CA1 region. Neuron. 1996 Sep; 17(3):475-82. Thomas MJ, Moody TD, Makhinson M, O'Dell TJ. PMID: 8816710.
      View in: PubMed   Mentions: 124     Fields:    Translation:AnimalsCells
    Michael's Networks
    Concepts (127)
    Derived automatically from this person's publications.
    _
    Co-Authors (2)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _